Caribou Biosciences, Inc. (CRBU)
NASDAQ: CRBU · Real-Time Price · USD
0.7675
-0.0175 (-2.23%)
Apr 4, 2025, 4:00 PM EDT - Market closed
Caribou Biosciences Market Cap
Caribou Biosciences has a market cap or net worth of $71.38 million as of April 4, 2025. Its market cap has decreased by -85.34% in one year.
Market Cap
71.38M
Enterprise Value
-149.89M
1-Year Change
-85.34%
Ranking
Category
Stock Price
$0.77
Market Cap Chart
Since the IPO on July 23, 2021, Caribou Biosciences's market cap has decreased from $888.48M to $71.38M, a decrease of -91.97%. That is a compound annual growth rate of -49.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 3, 2025 | 73.01M | -49.29% |
| Dec 31, 2024 | 143.98M | -71.59% |
| Dec 29, 2023 | 506.71M | 32.27% |
| Dec 30, 2022 | 383.09M | -57.82% |
| Dec 31, 2021 | 908.30M | 2.23% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 716.69B |
| UnitedHealth Group | 499.45B |
| Johnson & Johnson | 386.32B |
| AbbVie | 359.31B |
| Novo Nordisk | 301.38B |
| Abbott Laboratories | 229.47B |
| AstraZeneca | 225.76B |
| Merck & Co. | 218.51B |